Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

PHENEXPECT CD SYRUP

Approval Number

SIN06702P

Drug Name

PHENEXPECT CD SYRUP

Product Name

PHENEXPECT CD SYRUP

Approval Date

December 3, 1991

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Pharmacy Only

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

R05FB01

ATC Item Name

cough suppressants and mucolytics

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

ICM PHARMA PTE. LTD.

Active Ingredients

Ingredient Name

AMMONIUM CHLORIDE

Strength

135 mg/5 ml

Drug MonographAmmonium chloride

Ingredient Name

CODEINE PHOSPHATE

Strength

5.7 mg/5 ml

Drug MonographCodeine

Ingredient Name

DIPHENHYDRAMINE HCl

Strength

12.5 mg/5 ml

Drug MonographDiphenhydramine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

PHENEXPECT CD SYRUP - HSA Approval | MedPath